Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TScan Therapeutics (TCRX) Treasury Shares (2020 - 2021)

TScan Therapeutics (TCRX) has disclosed Treasury Shares for 2 consecutive years, with $116870.0 as the latest value for Q4 2021.

  • Quarterly Treasury Shares fell 73.33% to $116870.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $116870.0 through Dec 2021, down 73.33% year-over-year, with the annual reading at $116870.0 for FY2021, 73.33% down from the prior year.
  • Treasury Shares for Q4 2021 was $116870.0 at TScan Therapeutics, down from $204513.0 in the prior quarter.
  • The five-year high for Treasury Shares was $438280.0 in Q4 2020, with the low at $116870.0 in Q4 2021.